Technical Analysis for ZYNE - Zynerba Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 5.26 -2.41% -0.13
ZYNE closed down 2.41 percent on Friday, May 29, 2020, on 1.44 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical ZYNE trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Upper Bollinger Band Walk Strength -2.41%
Wide Bands Range Expansion -2.41%
Down 3 Days in a Row Weakness -2.41%
200 DMA Resistance Bearish -5.90%
Slingshot Bullish Bullish Swing Setup -5.90%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Company has two product candidates, including ZYN002 and ZYN001, which represent cannabinoid therapeutics for several indications, including refractory epilepsy, Fragile X syndrome (FXS), osteoarthritis (OA), fibromyalgia and peripheral neuropathic pain. ZYN002 is a synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. In preclinical animal studies, ZYN002's permeation enhancer increased delivery of CBD through the layers of the skin and into the circulatory system. ZYN001 is a pro-drug of delta-9-tetrahydrocannabinol (THC) that enables transdermal delivery through a patch. In preclinical animal studies, ZYN001 demonstrated effective skin permeation with sustained delivery and rapid conversion of ZYN001 to THC.
Pharmaceutical Pain Drugs Chemical Compounds Osteoarthritis Psychoactive Drugs Entheogens Fibromyalgia Cannabidiol Cannabinoids Fragile X Syndrome

Is ZYNE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.6973
52 Week Low 2.55
Average Volume 848,059
200-Day Moving Average 6.22
50-Day Moving Average 4.15
20-Day Moving Average 4.69
10-Day Moving Average 5.38
Average True Range 0.53
ADX 35.1
+DI 33.92
-DI 16.27
Chandelier Exit (Long, 3 ATRs ) 5.21
Chandelier Exit (Short, 3 ATRs ) 5.11
Upper Bollinger Band 6.37
Lower Bollinger Band 3.00
Percent B (%b) 0.67
BandWidth 72.10
MACD Line 0.46
MACD Signal Line 0.38
MACD Histogram 0.0802
Fundamentals Value
Market Cap 69.73 Million
Num Shares 13.3 Million
EPS -2.60
Price-to-Earnings (P/E) Ratio -2.02
Price-to-Sales 0.00
Price-to-Book 1.77
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.01
Resistance 3 (R3) 6.03 5.81 5.89
Resistance 2 (R2) 5.81 5.62 5.80 5.84
Resistance 1 (R1) 5.53 5.50 5.42 5.51 5.80
Pivot Point 5.31 5.31 5.25 5.30 5.31
Support 1 (S1) 5.03 5.12 4.92 5.01 4.72
Support 2 (S2) 4.81 5.00 4.80 4.68
Support 3 (S3) 4.53 4.81 4.64
Support 4 (S4) 4.51